Nanobodies: new avenue to treat kidney disease

Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discus...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanner, Nicola, Eden, Thomas, Liaukouskaya, Nastassia, Koch-Nolte, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205650/
https://www.ncbi.nlm.nih.gov/pubmed/34131806
http://dx.doi.org/10.1007/s00441-021-03479-8
_version_ 1783708544322764800
author Wanner, Nicola
Eden, Thomas
Liaukouskaya, Nastassia
Koch-Nolte, Friedrich
author_facet Wanner, Nicola
Eden, Thomas
Liaukouskaya, Nastassia
Koch-Nolte, Friedrich
author_sort Wanner, Nicola
collection PubMed
description Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.
format Online
Article
Text
id pubmed-8205650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82056502021-06-16 Nanobodies: new avenue to treat kidney disease Wanner, Nicola Eden, Thomas Liaukouskaya, Nastassia Koch-Nolte, Friedrich Cell Tissue Res Review Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases. Springer Berlin Heidelberg 2021-06-16 2021 /pmc/articles/PMC8205650/ /pubmed/34131806 http://dx.doi.org/10.1007/s00441-021-03479-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Wanner, Nicola
Eden, Thomas
Liaukouskaya, Nastassia
Koch-Nolte, Friedrich
Nanobodies: new avenue to treat kidney disease
title Nanobodies: new avenue to treat kidney disease
title_full Nanobodies: new avenue to treat kidney disease
title_fullStr Nanobodies: new avenue to treat kidney disease
title_full_unstemmed Nanobodies: new avenue to treat kidney disease
title_short Nanobodies: new avenue to treat kidney disease
title_sort nanobodies: new avenue to treat kidney disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205650/
https://www.ncbi.nlm.nih.gov/pubmed/34131806
http://dx.doi.org/10.1007/s00441-021-03479-8
work_keys_str_mv AT wannernicola nanobodiesnewavenuetotreatkidneydisease
AT edenthomas nanobodiesnewavenuetotreatkidneydisease
AT liaukouskayanastassia nanobodiesnewavenuetotreatkidneydisease
AT kochnoltefriedrich nanobodiesnewavenuetotreatkidneydisease

Ejemplares similares